HL-1 cardiomyocyte line: characteristics, applications, and research progress
Cardiomyocytes are the fundamental units of cardiac function, and their structural and functional abnormalities are closely related to various cardiovascular diseases. However, the difficulty in obtaining primary cardiomyocytes and their limited proliferation ability limit their application in in vitro studies. The establishment of HL-1 cardiomyocyte line provides an important tool for cardiomyocyte biology research.
- Recent Advances
- Reference
Abstract
1. Introduction
2. Biological Characteristics of the HL-1 Cell Line
Spontaneous Contraction: HL-1 cells exhibit spontaneous contractions in vitro at a frequency of approximately 60-120 beats per minute, mimicking the rhythmic activity of cardiomyocytes in vivo.
Electrophysiological Traits: HL-1 cells express various ion channels, including delayed rectifier potassium current (Ikr), L-type calcium current (ICa,L), and inward rectifier potassium current (IK1), with electrophysiological properties comparable to adult atrial cardiomyocytes.
Gene Expression: HL-1 cells express cardiomyocyte-specific markers such as α-myosin heavy chain (α-MHC), α-cardiac actin, and connexin 43, while secreting atrial natriuretic factor (ANF).
3. Application Fields of the HL-1 Cell Line
Cardiac Hypertrophy: By simulating pressure overload or hormonal stimulation, HL-1 cells are used to investigate signaling pathways (e.g., MAPK, PI3K/Akt) and key gene regulation (e.g., β-MHC, ANF) in myocardial hypertrophy. For example, studies have shown that AngII-induced hypertrophy in HL-1 cells is associated with increased calcineurin activity.
Arrhythmias: The electrophysiological properties of HL-1 cells make them an ideal model for studying arrhythmia mechanisms. Hypoxia or drug interventions in HL-1 cells can induce abnormal action potential duration and repolarization dispersion, mimicking clinical arrhythmic phenotypes.
Ischemia-Reperfusion Injury: Using oxygen-glucose deprivation (OGD) models, HL-1 cells help explore pathophysiological processes in myocardial ischemia-reperfusion, such as oxidative stress, apoptosis, and energy metabolism disorders.
Development of Cardioprotective Drugs: HL-1 cells are used to screen drugs with anti-hypertrophic, anti-apoptotic, or antioxidant effects. For instance, Apelin-13 inhibits AngII-induced hypertrophy in HL-1 cells via the AMPK/mTOR signaling pathway.
Cardiotoxicity Assessment: HL-1 cells evaluate potential myocardial toxicity of drugs, such as chemotherapy-induced myocardial damage and arrhythmias caused by doxorubicin.
Gene Editing Applications: CRISPR/Cas9 technology enables gene knockout or overexpression in HL-1 cells to study specific gene roles in cardiomyocyte function. For example, knocking out the Neurogranin (Ng) gene causes calcium homeostasis imbalance and hypertrophy in HL-1 cells.
Signal Pathway Analysis: HL-1 cells facilitate investigations into intracellular signaling networks, including β-adrenergic receptor pathways, calcium signaling, and metabolic regulatory pathways.
Cell-Cell Interaction Studies: Co-culturing HL-1 cells with mesenchymal stem cells (MSCs) promotes myocardial repair and regeneration via gap junctions and membrane component exchange.
Organoid Construction: Co-culturing HL-1 cells with other cell types (e.g., endothelial cells, fibroblasts) constructs cardiac organoids, simulating the 3D structure and function of cardiac tissue.
4. Research Progress and Technological Innovations
5. Limitations and Future Directions
Phenotypic Stability: While HL-1 cells retain cardiomyocyte phenotypes during passage, long-term culture may cause heterogeneity and functional decline, requiring periodic characterization.
Model Limitations: Derived from tumor cells, HL-1 cells differ biologically from primary cardiomyocytes, necessitating in vivo validation of in vitro findings.
Medium Dependence: HL-1 cell growth relies on specialized Claycomb medium, which is costly and complex, limiting widespread use.
Culture System Optimization: Develop serum-free or chemically defined media to reduce costs and improve culture stability.
Multi-Omics Integration: Combine genomic, transcriptomic, and metabolomic data to comprehensively 解析 HL-1 cell biology and disease mechanisms.
Organoids and Bioprinting: Use 3D bioprinting to construct cardiac organoids containing HL-1 cells, simulating complex cardiac tissue structure and function for more realistic drug screening and regenerative models.
Artificial Intelligence and Machine Learning: Apply AI algorithms to analyze HL-1 cell electrophysiological and imaging data, enhancing disease prediction and drug development efficiency.
6. Conclusion
This article is reviewed and published by the technical expert team of UA
Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.
Purchase recombinant protein, choose 
UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.
Business license (three certificates in one) 
